Vimarsana
Biggest News Aggregation in the World

Page 10 - Sciences Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sciences Corp Today - Breaking & Trending Today

Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner - Vimarsana News

Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner

Company also receives national and regional Top Workplace honors from USA Today and Wisconsin State Journal ...

Baystreet.ca - Exact Science Cops Gallup Award - Vimarsana News

Baystreet.ca - Exact Science Cops Gallup Award

Exact Sciences Corp. (NASDAQ: EXAS) shares hiked Wednesday. The company, a leading provider of cancer screening and diagnostic tests, today announced it has received the 2024 Gallup Exceptional Workplace Award (GEWA). This award recognizes the most engaged ...

The New England Journal of Medicine Publishes Cologuard Plus Test Results from Pivotal BLUE-C Study - Vimarsana News

The New England Journal of Medicine Publishes Cologuard Plus Test Results from Pivotal BLUE-C Study

13.03.2024 - Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced online publication of the BLUE-C study results in The New England Journal of Medicine. The peer-reviewed study, 'Next-Generation ... Seite 1

The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study - Vimarsana News

The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study

Cologuard Plus is only noninvasive test to be evaluated head-to-head against an independent fecal immunochemical test, which it significantly outperformed 20,000-participant BLUE-C study included...

Exact Sciences Launches Riskguard™ Hereditary Cancer Test in the United States - Vimarsana News

Exact Sciences Launches Riskguard™ Hereditary Cancer Test in the United States

MADISON, Wis.--(BUSINESS WIRE)--Feb 28, 2024--